Vid Stojevic, Kuano’s CEO is attending the J.P. Morgan Healthcare Conference

Written By Jarryl D'Oyley

Interested in connecting with KUANO at JPM in San Francisco, learn more about how we are delivering the next generation of small molecule enzyme inhibitors based on advanced quantum simulations supported by AI? Reach out to schedule a meeting with the team here: contact@kuano.ai

Jarryl D'Oyley
Previous

Kuano has made the shortlist for the @cofinitive #21toWatch award.
Next

Mercia discusses why they invested in Kuano